Exact Mass: 323.14

Exact Mass Matches: 323.14

Found 12 metabolites which its exact mass value is equals to given mass value 323.14, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Renzapride

4-Amino-N-{1-azabicyclo[3.3.1]nonan-4-yl}-5-chloro-2-methoxybenzene-1-carboximidate

C16H22ClN3O2 (323.14)


   

TEB_M324a

TEB_M324a

C16H22ClN3O2 (323.14)


CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2501

   

TEB_M324b *

TEB_M324b *

C16H22ClN3O2 (323.14)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2504

   

TEB_M324c

TEB_M324c

C16H22ClN3O2 (323.14)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2505

   

Renzapride

Renzapride

C16H22ClN3O2 (323.14)


Renzapride (BRL 24924), a substituted benzamide, is a full 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride (BRL 24924) is also a 5HT2b and 5HT3 receptor antagonist[1]. Renzapride could be used for constipation predominant irritable bowel syndrome (C-IBS) study[2].

   
   

2-chloro-N-cyclopentyl-5-(3,3-diethoxy-1-propyn-1-yl)-4-Pyrimidinamine

2-chloro-N-cyclopentyl-5-(3,3-diethoxy-1-propyn-1-yl)-4-Pyrimidinamine

C16H22ClN3O2 (323.14)


   

Benzamide, 4-amino-N-1-azabicyclo(3.3.1)non-4-yl-5-chloro-2-methoxy-

Benzamide, 4-amino-N-1-azabicyclo(3.3.1)non-4-yl-5-chloro-2-methoxy-

C16H22ClN3O2 (323.14)


   

5-(4-Chlorophenyl)-2,2-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentane-1,3-diol

5-(4-Chlorophenyl)-2,2-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentane-1,3-diol

C16H22ClN3O2 (323.14)


   

1-[(2r)-2-Aminobutanoyl]-N-(3-Chlorobenzyl)-L-Prolinamide

1-[(2r)-2-Aminobutanoyl]-N-(3-Chlorobenzyl)-L-Prolinamide

C16H22ClN3O2 (323.14)


   

Renzaprida

Renzaprida

C16H22ClN3O2 (323.14)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

(S)-Renzapride

(S)-Renzapride

C16H22ClN3O2 (323.14)


(S)-Renzapride ((S)-BRL 24924) is the isomer of HY-14147 Renzapride. Renzapride is a 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride also is a 5HT2b and 5HT3 receptor antagonist. Renzapride can be used for constipation predominant irritable bowel syndrome (C-IBS) study[1][2].